← К результатам

CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy.

Philippidis A

Human gene therapy, 35(1-2): 1-4 PMID 38231658 DOI 10.1089/hum.2023.29263.bfs